Supriya Agnihotri, Gurvirender Singh, Santosh Kumar Verma
Supriya Agnihotri1, Gurvirender Singh2*, Santosh Kumar Verma3
1Chandigarh College of Pharmacy, Chandigarh Group of Colleges, Landran 140307, Punjab, India.
2Research Scholar, I. K. Gujral Punjab Technical University, Kapurthala 144603, Punjab, India.
3Motherhood University, Roorkee, 247661, Uttarakhand, India.
Volume - 14,
Issue - 6,
Year - 2021
Looking at the increasing prevalence and inadequate treatments for diabetes mellitus, this study was carried to trace out hypoglycemic potentials of Typha elephantina leaves using in vitro and in vivo studies. a -amylase and a-glucosidase in vitro enzyme inhibition assay were incorporated to determine percent inhibition of Typha elephantina extracts. Typha elephantina methanol extract (TEME) at 125µg/ml in both a-amylase and a-glucosidase exhibited 57.48±1.42 and 53.64±0.92 percent inhibition in contrast to 66.7±0.94 and 70.31±1.25 of standard Acarbose, respectively. However, results obtained in Typha elephantina petroleum ether and chloroform extracts were insignificant. Further TEME antidiabetic properties were investigated by in vivo study, using Streptozotocin induced diabetic rats. Selected 250mg/kg and 500mg/kg doses of TEME were administered orally, which significantly (?? < 0.001) reduces blood glucose of treated animals in contrast to diabetic control. 500mg/kg dose of TEME reduces blood glucose more efficiently. A significant linear rise of body weight and HDL were observed, while there was also remarkable reduction in cholesterol, TG, LDL, VLDL. Reduction in Liver function SGOT, SGPT along with creatinine and urea levels were observed in contrast to diabetic control group. In addition, antioxidant study of Typha elephantina extracts reflected significant results in comparison to that of ascorbic acid in DPPH and H2O2 assay. The whole study signified that Typha elephantina has hypoglycemic potentials.
Cite this article:
Supriya Agnihotri, Gurvirender Singh, Santosh Kumar Verma. Antihyperglycemic activity of Typha elephantina leaves using in vivo and in vitro Techniques. Research Journal of Pharmacy and Technology. 2021; 14(6):3150-6. doi: 10.52711/0974-360X.2021.00549
Supriya Agnihotri, Gurvirender Singh, Santosh Kumar Verma. Antihyperglycemic activity of Typha elephantina leaves using in vivo and in vitro Techniques. Research Journal of Pharmacy and Technology. 2021; 14(6):3150-6. doi: 10.52711/0974-360X.2021.00549 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-39
1. El-Atat F, McFarlane SI and Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Current Hypertension Reports. 2004; 6(3): 215-23.
2. Goyal R and Jialal I. Diabetes Mellitus Type 2: Stat Pearls Publishing; 2019.
3. Organization WH. The world health report: 1999: making a difference: World Health Organization; 1999.
4. Kharroubi AT and Darwish HM. Diabetes mellitus: The epidemic of the century. World Journal of Diabetes. 2015; 6(6): 850.
5. Ahmed AM. History of diabetes mellitus. Saudi Medical Journal. 2002; 23(4): 373-8.
6. Wang Z, Zhao X, Liu X, Lu W, Jia S, Hong T, Li R, Zhang H, Peng L and Zhan X. Anti-diabetic activity evaluation of a polysaccharide extracted from Gynostemma pentaphyllum. International Journal of Biological Macromolecules. 2019; 126: 209-14.
7. Maheshwari RA, Khatri K, Sailor G and Balaraman R. Antidiabetic activity of Dibolin (a polyherbal formulation) in streptozotocin-nicotinamide induced type 2 diabetic rats. Int J Pharm Pharm Sci. 2014; 2: 893-7.
8. Khan Y, Gupta P, Bihari B and Verma VKJAJoPR. A Review on Diabetes and Its Management. 2013; 3(1): 28-33.
9. Shrestha AD, Kosalram K and Gopichandran V. Gender difference in care of type 2 diabetes. Journal of the Nepal Medical Association. 2013; 52(189).
10. Atlas ID. Brussels, Belgium: international diabetes federation; 2013. International Diabetes Federation. 2017.
11. Verspohl E. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacological Reviews. 2012; 64(2): 188-237.
12. Kaur HJAJoNE and Research. Effectiveness of structured teaching programme regarding self care management in relation to prevention of complications among diabetics. 2014; 4(3): 279-83.
13. Sabu M and Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. Journal of Ethnopharmacology. 2002; 81(2): 155-60.
14. Sharma A, Shanker C, Tyagi LK, Singh M and Rao CV. Herbal medicine for market potential in India: an overview. Acad J Plant Sci. 2008; 1(2): 26-36.
15. Organization WH. WHO Expert Committee on Diabetes Mellitus [meeting held in Geneva from 25 September to 1 October 1979]: second report. 1980.
16. Tripathi S, Saroj BK, Khan MYJAJoP and Technology. Pharmacological Evaluation of Folk Medicinally used Plant by usin Streptozotocin Induced Rat Models. 2018; 8(4): 231-43.
17. Tiwari AK and Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Current Science. 2002: 30-8.
18. Ruangrungsi N, Aukkanibutra A, Phadungcharoen T and Lee M. Constituents of Typha elephantina. Scientific Society. 1987; 13: 57-62.
19. Sharma K and Gopal B. A note on the identity of Typha elephantina roxb. Aquatic Botany. 1980; 9: 381-7.
20. Moniruzzaman M, Rahman M, Aktar S and Khan M. Equilibrium and Kinetic Parameters Determination of Cr (VI) Adsorption by Hogla Leaves (Typha elephantina Roxb.). International Journal of Waste Resources. 2017; 7(301): 2.
21. Uddin M, Mukul SA, Khan M, Chowdhury M, Uddin M and Fujikawa S. Indigenous management practices of Hogla (Typha elephantina Roxb.) in local plantations of floodplain areas of Bangladesh. Subtropical Agriculture Research and Development. 2006; 4(3): 114-9.
22. Zhou B, Tu T, Kong F, Wen J and Xu X. Revised phylogeny and historical biogeography of the cosmopolitan aquatic plant genus Typha (Typhaceae). Scientific Reports. 2018; 8(1): 8813.
23. Boulos L. Flora of egypt: Al Hadara Publishing Cairo; 2005.
24. Sharma K and Gopal B. Seed germination and occurrence of seedlings of Typha species in nature. Aquatic Botany. 1978; 4: 353-8.
25. Bhatti J, Veer V and Negi B. Discovery of the natural habitat of the aquatic thysanopteran, Organothrips indicus (Terebrantia: Thripidae) in India and North America. Oriental Insects. 1998; 32(1): 259-66.
26. Khare CP. Ayurvedic pharmacopoeial plant drugs: expanded therapeutics: Routledge; 2015.
27. Council NR. Guide for the care and use of laboratory animals: National Academies Press; 2010.
28. Sudha P, Zinjarde SS, Bhargava SY and Kumar AR. Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC Complementary and Alternative Medicine. 2011; 11(1): 5.
29. Anarthe S, Chaudhari SJRJoP and Phytochemistry. Hypoglycemic Activity of Leucas linifolia (Lamiaceae) Spreng. 2011; 3(1): 34-7.
30. Rani A, Kumar S and Khar RK. In Vitro Antidiabetic and Hypolipidemic Activity of Selected Medicinal Plants.
31. Kumar DL, Rao K, Bindu M, Kumar DS, David BJRJoP and Pharmacodynamics. Alpha-Glucosidase Inhibitory Activities of Wrightia tinctoria Roxb and Schrebera swietenoides Roxb Bark Extract. 2011; 3(1): 22-4.
32. Tiwari P and Patel RKJAJoPA. Estimation of total phenolics and flavonoids and antioxidant potential of Ashwagandharishta prepared by Traditional and Modern Methods. 2013; 3(4): 147-52.
33. Krishna KV, Karuppuraj V and Perumal KJAJoPA. Antioxidant activity and Folic acid content in indigenous isolates of Ganoderma lucidum. 2016; 6(4): 213-5.
34. Nabavi S, Ebrahimzadeh M, Nabavi S, Hamidinia A and Bekhradnia A. Determination of antioxidant activity, phenol and flavonoids content of Parrotia persica Mey. Pharmacologyonline. 2008; 2(9): 560-7.
35. Potbhare M, Phendarkar N and Khobragade DJAJoRiPS. In vitro Evaluation of Antioxidant Potential of N-Acetyl-D-Glucosamine. 2017; 7(2): 120-2.
36. Verma A, Jana GK, Sen S, Chakraborty R, Sachan S and Mishra A. Pharmacological evaluation of Saraca indica leaves for central nervous system depressant activity in mice. J Pharm Sci Res. 2010; 2(6): 338-43.
37. Pandit R, Phadke A and Jagtap A. Antidiabetic effect of Ficus religiosa extract in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology. 2010; 128(2): 462-6.
38. Thippeswamy B, Mishra B, Veerapur V and Gupta G. Anxiolytic activity of Nymphaea alba Linn. in mice as experimental models of anxiety. Indian Journal of Pharmacology. 2011; 43(1): 50.
39. Udia P, Ogbonna O, Antai A, Mbatutung I, Eyo SJRJoP and Phytochemistry. Oral glucose tolerance test and some haematological effects of aqueous leaf extract of Rothmannia hispida (K. Schunn) fargel on normoglycaemic albino rats. 2013; 5(6): 300-5.
40. Kaushik P, Kaushik D, Khokra SL and Sharma A. Antidiabetic activity of the plant Abutilon indicum in streptozotocin-induced experimental diabetes in rats. Int J Pharmacog Phytochem Res. 2010; 2: 45-9.
41. Aslan M, Orhan DD, Orhan N, Sezik E and Yesilada E. In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. Journal of Ethnopharmacology. 2007; 109(1): 54-9.
42. Muruganandan S, Srinivasan K, Gupta S, Gupta P and Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. Journal of Ethnopharmacology. 2005; 97(3): 497-501.
43. Nayak Y, Hillemane V, Daroji VK, Jayashree B and Unnikrishnan M. Antidiabetic activity of benzopyrone analogues in nicotinamide-Streptozotocin induced Type 2 diabetes in rats. The Scientific World Journal. 2014; 2014.
44. Raj SM, Mohammed S, Kumar SV, Debnath SJRJoP and Phytochemistry. Antidiabetic effect of Luffa acutangula fruits and histology of organs in streptozotocin induced diabetic in rats. 2012; 4(2): 64-9.
45. Saifi A, Chauhan R and Dwivedi JJAJoPR. Development of a polyherbal formulation FMST and evaluation for antidiabetic activity in alloxan induced diabetic rats. 2017; 7(1): 1-7.